CEBIX INC has a total of 17 patent applications. Its first patent ever was published in 2006. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals and biotechnology are JIANGYIN USUN PHARMACEUTICAL CO LTD, RIPTIDE BIOSCIENCE INC and FAVRILLE INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | Canada | 2 | |
#5 | China | 1 | |
#6 | Republic of Korea | 1 | |
#7 | Mexico | 1 | |
#8 | New Zealand | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Callaway James | 13 |
#2 | Barrack Sheri | 10 |
#3 | Mazzoni Michelle | 9 |
#4 | Wahren John | 7 |
#5 | Ekberg Karin | 4 |
#6 | Carlsson Anders | 1 |
Publication | Filing date | Title |
---|---|---|
US2013316946A1 | Extended recombinant polypeptide-modified c-peptide | |
US2015087586A1 | Pegylated c-peptide | |
MX2012013375A | Pegylated c-peptide. | |
WO2011081915A2 | Methods for treating erectile dysfunction in patients with insulin-dependent diabetes | |
US7855177B1 | Methods and kits for preventing hypoglycemia |